These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 3961578)
1. [Treatment of erysipelas in late middle-aged patients]. Kriukova ZV; Kriukova SA; Panichkina LN Sov Med; 1986; (1):91-3. PubMed ID: 3961578 [No Abstract] [Full Text] [Related]
2. [Effectiveness in treating patients with different clinical forms of erysipelas]. Kriukova ZV; Kriukova SA; Panichkina LN Vrach Delo; 1986 Aug; (8):121-2. PubMed ID: 3776149 [No Abstract] [Full Text] [Related]
3. [Comparative evaluation of the results of the treatment of erysipelas]. Brisker AD; Ebert LIa; Khlestkov AA Sov Med; 1973 Dec; 36(12):122-3. PubMed ID: 4130664 [No Abstract] [Full Text] [Related]
4. [Immunomodulating therapy of middle-aged and elderly patients with erysipelas]. Frolov VM; Rychnev VE; Razenkova AT; Baskakov IN; Gurina AA Vrach Delo; 1987 Jul; (7):103-5. PubMed ID: 3630100 [No Abstract] [Full Text] [Related]
5. [Use of pyrogenal in the combined therapy of erysipelas]. Zhivitsa LV; Zeĭgermakher GA; Knysh EN; Predeina VA Vrach Delo; 1986 Oct; (10):24-6. PubMed ID: 3798883 [No Abstract] [Full Text] [Related]
6. [Effectiveness of prodigiozan in the complex treatment of erysipelas]. Frolov VM; Rychnev VE Klin Med (Mosk); 1984 Aug; 62(8):123-6. PubMed ID: 6387266 [No Abstract] [Full Text] [Related]
7. [Effectiveness of the use of zaditen and leakadin in recurrent erysipelas]. Frolov VM; Peresadin NA; Pinskiĭ LL; Korobka IuN; Pustovoĭ IuG Ross Med Zh; 1992; (3):38-9. PubMed ID: 1643358 [No Abstract] [Full Text] [Related]
8. [Characteristics of the clinical course of erysipelas in the middle-aged and elderly]. Postovit VA; Mel'k MV Sov Med; 1981; (3):100-4. PubMed ID: 7244822 [No Abstract] [Full Text] [Related]
9. [Immune preparations in the overall therapy and prevention of erysipelatous inflammation]. Khlestkov AA; Raskovalov MG; Ebert LIa Voen Med Zh; 1976 Jan; (1):48-9. PubMed ID: 1258419 [No Abstract] [Full Text] [Related]
11. [Thymalin in the treatment of patients with erysipelas]. Pateiuk VG; Budazhabon GB; Kuznik BI; Morozov VG; Sergeeva EI Klin Med (Mosk); 1987 Jul; 65(7):110-4. PubMed ID: 3312790 [No Abstract] [Full Text] [Related]
12. [Pyrogenal in the combined therapy of erysipelatous inflammation]. Frolov VM; Shlykova SI Sov Med; 1984; (1):95-8. PubMed ID: 6701664 [No Abstract] [Full Text] [Related]
13. [Erysipelas in the young population of a military hospital]. Mahé E; Toussaint P; Lamarque D; Boutchnei S; Guiguen Y Ann Dermatol Venereol; 1999; 126(8-9):593-9. PubMed ID: 10530346 [TBL] [Abstract][Full Text] [Related]
14. [The treatment of patients with recurrent erysipelas using corticosteroid hormones]. Lopatina ZhM Vrach Delo; 1966 Apr; 4():104-7. PubMed ID: 5990514 [No Abstract] [Full Text] [Related]
15. [Principles of treatment of patients with recurrent erysipelas]. Cherkasov VL; Samotolkin KN Vrach Delo; 1983 Feb; (2):113-6. PubMed ID: 6845687 [No Abstract] [Full Text] [Related]
16. [The treatment of patients with the hemorrhagic form of erysipelas by using amben and parmidine]. Cherkasov VL; Bol'shakova TD; Kuznetsov VA; Obrazberdyev S; Mikerin SM Vrach Delo; 1990 Apr; (4):113-5. PubMed ID: 2275146 [TBL] [Abstract][Full Text] [Related]
18. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. Lazzarini L; Conti E; Tositti G; de Lalla F J Infect; 2005 Dec; 51(5):383-9. PubMed ID: 16321649 [TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of dekaris in treating patients with various forms of erysipelas]. Sulaĭmenova ZI; Tsoĭ IG Klin Med (Mosk); 1986 Feb; 64(2):138-40. PubMed ID: 3702289 [No Abstract] [Full Text] [Related] [Next] [New Search]